Raimund Johannes Ober

Title: Raimund Johannes Ober: Innovator in Antibody Depletion Methods

Introduction

Raimund Johannes Ober is a notable inventor based in Southampton, GB. He has made significant contributions to the field of medical science, particularly in the area of antibody depletion. His innovative work has led to the development of a unique method that addresses specific medical challenges.

Latest Patents

Raimund Johannes Ober holds a patent for a method of depleting target antigen-specific antibodies from a patient by administering a fusion protein known as 'Seldeg'. This fusion protein includes a targeting component that specifically binds to a cell surface receptor or other cell surface molecule at near-neutral pH. The antigen component is designed to specifically bind to a target antigen-specific antibody. This method provides a novel approach to selectively depleting antigen-specific antibodies in patients, showcasing Ober's commitment to advancing medical treatments.

Career Highlights

Ober is affiliated with The Texas A&M University System, where he continues to engage in research and development. His work is characterized by a focus on innovative solutions to complex medical problems. With a patent portfolio that includes 1 patent, he has established himself as a key figure in his field.

Collaborations

Some of his notable coworkers include Elizabeth Sally Ward Ober and Venkata Siva Charan Devanaboyina. Their collaborative efforts contribute to the advancement of research and innovation in the medical field.

Conclusion

Raimund Johannes Ober's contributions to the field of antibody depletion through his innovative methods highlight his role as a significant inventor. His work not only advances scientific understanding but also has the potential to improve patient outcomes in medical treatments.